Association between low sniff nasal-inspiratory pressure (SNIP) and sleep disordered breathing in amyotrophic lateral sclerosis: Preliminary results

Amyotrophic Lateral Sclerosis

Volumn 12, Issue 6, 2011, Pages 458-463

  Carratú, Pierluigi ^a   Cassano, Anna ^a   Gadaleta, Felice ^a   Tedone, Mariangela ^a   Dongiovanni, Salvatore ^a   Fanfulla, Francesco ^b   Resta, Onofrio ^a  

^a UNIVERSITY OF BARI   (Italy)

^b IRCCS   (Italy)

Author keywords

ALS; FVC; sleep disordered breathing; SNIP

Indexed keywords

OXYHEMOGLOBIN;

ADULT; AGED; AIRWAY PRESSURE; AMYOTROPHIC LATERAL SCLEROSIS; ARTERIAL OXYGEN TENSION; ARTICLE; BREATHING MUSCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FORCED VITAL CAPACITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; LOW SNIFF NASAL INSPIRATORY PRESSURE; LUNG FUNCTION TEST; MALE; NIGHT SLEEP; OXYGEN SATURATION; POLYSOMNOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; HUMANS; INHALATION; MALE; MIDDLE AGED; NOSE; OXYGEN; PRESSURE; RESPIRATORY FUNCTION TESTS; SLEEP APNEA SYNDROMES;

EID: 80055035418     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2011.593038     Document Type: Article

References (29)

1. Stambler N, Ringel SP, Murphy JR, Alderson MK, Bryan W, England JD, et al. The natural history of amyotrophic lateral sclerosis. Neurology. 1993;43:1316-22. (Pubitemid 23213802)
2. Kurian KM, Forbes RB, Colville S, Swingler RJ. Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register. J Neurol Neurosurg Psychiatry. 2009;80:84-7.
3. Stambler N, Charatan M, Cedarbaum JM. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology. 1998;50:66-72. (Pubitemid 28106021)
4. Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufi t R, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology. 1999;52:1311-23. (Pubitemid 29190518)
5. Czaplinski A, Yen AA, Appel SH. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry. 2006;77:390-2.
6. Carrat ù P, Spicuzza L, Cassano A, 6. Maniscalco M, Gadaleta F, Lacedonia D, et al. Early treatment with non-invasive positive pressure ventilation prolongs survival in amyotrophic lateral sclerosis patients with nocturnal respiratory insuffi-ciency. Orphanet J Rare Dis. 2009;10:4-10.
7. Lyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain. 2001;124:2000-13. (Pubitemid 32945900)
8. Ward NS, Hill NS. Pulmonary function testing in neuromuscular disease. Clin Chest Med. 2001;22:769-81. Review. (Pubitemid 34020013)
9. Schmidt EP, Drachman DB, Wiener CM, Clawson L, Kimball R, Lechtzin N. Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design. Muscle Nerve. 2006;33:127-32. (Pubitemid 43062995)
10. Baumann F, Henderson RD, Morrison SC, Brown M, Hutchinson N, Douglas JA, et al. Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:194-202.
11. Héritier F, Rahm F, Pasche P, Fitting JW. Sniff nasal inspiratory pressure. A non-invasive assessment of inspiratory muscle strength. Am J Respir Crit Care Med. 1994;150:1678-83.
12. Chaudri MB, Liu C, Watson L, Jefferson D, Kinnear WJ. Sniff nasal inspiratory pressure as a marker of respiratory function in motor neuron disease. Eur Respir J. 2000;15:539-42. (Pubitemid 30158192)
13. Stefanutti D, Benoist MR, Scheinmann P, Chaussain M, Fitting JW. Usefulness of sniff nasal pressure in patients with neuromuscular or skeletal disorders. Am J Respir Crit Care Med. 2000;162:1507-11.
14. Fitting JW, Paillex R, Hirt L, Aebischer P, Schluep M. Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis. Ann Neurol . 1999;46:887-93.
15. Morgan RK, McNally S, Alexander M, Conroy R, Hardiman O, Costello RW. Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2005;171:269-74.
16. Gay PC, Westbrook PR, Daube JR, Litchy WJ, Windebank AJ, Iverson R. Effects of alterations in pulmonary function and sleep variables on survival in patients with amyotrophic lateral sclerosis. Mayo Clin Proc . 1991;66:686-94.
17. Ferguson KA, Strong MJ, Ahmad D, George CF. Sleepdisordered breathing in amyotrophic lateral sclerosis. Chest. 1996;110:664-9. (Pubitemid 27009289)
18. K imura K, Tachibana N, Kimura J, Shibasaki H. Sleepdisordered breathing at an early stage of amyotrophic lateral sclerosis . J Neurol Sci . 1999;164:37-43. (Pubitemid 29256071)
19. Newsom-Davis IC, Lyall RA, Leigh PN, Moxham J, Goldstein LH . The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in amyotrophic lateral sclerosis (ALS): a prospective study . J Neurol Neurosurg Psychiatry. 2001;71:482-7. (Pubitemid 32906871)
20. Bradley WG. Overview of motor neuron disease: classifi cation and nomenclature. Clin Neurosci. 1995;3:323-6. (Pubitemid 27052165)
21. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III ) . J Neurol Sci. 1999;169:13-21. (Pubitemid 29502501)
22. American Thoracic Society: Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152: 1107-36.
23. Marrone O, Salvaggio A, Insalaco G, Bonsignore MR, Bonsignore G. Evaluation of the POLYMESAM system in the diagnosis of obstructive sleep apnoea syndrome. Monaldi Arch Chest Dis. 2001;56:486-90. (Pubitemid 34406644)
24. Punjabi NM, Newman AB, Young TB, Resnick HE, Sanders MH. Sleep-disordered breathing and cardiovascular disease: an outcome-based defi nition of hypopnoeas. Am J Respir Crit Care Med. 2008;177:1150-5. (Pubitemid 351717575)
25. Fallat RJ, Jewitt B, Bass M, Kamm B, Norris FH Jr. Spirometry in amyotrophic lateral sclerosis. Arch Neurol. 1979;36: 74-80. (Pubitemid 9083183)
26. Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufi t R, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence based review). Muscle Nerve. 1999;22:1104-85.
27. Just N, Bautin N, Danel-Brunaud V, Debroucker V, Matran R, Perez T. The Borg dyspnoea score: a relevant clinical marker of inspiratory muscle weakness in amyotrophic lateral sclerosis. Eur Respir J. 2010;35:353-60.
28. Pinto S, Geraldes R, Vaz N, Pinto A, de Carvalho M. Changes of the phrenic nerve motor response in amyotrophic lateral sclerosis: longitudinal study. Clin Neurophysiol. 2009;120: 2082-5.
29. Murphy P, Lyall R, Hart N, Polkey MI. Assessment of respiratory muscle strength in motor neuron disease: is asking enoughEur Respir J. 2010;35:245-6.